CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 89 filers reported holding CULLINAN ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,169,511 | +6.6% | 239,725 | +26.8% | 0.00% | 0.0% |
| Q2 2023 | $2,034,425 | +81212.0% | 189,073 | -22.7% | 0.00% | 0.0% |
| Q1 2023 | $2,502 | +10.7% | 244,553 | +14.1% | 0.00% | 0.0% |
| Q4 2022 | $2,261 | -99.9% | 214,269 | +43.4% | 0.00% | 0.0% |
| Q3 2022 | $1,915,000 | -53.6% | 149,407 | -53.6% | 0.00% | -66.7% |
| Q2 2022 | $4,124,000 | +3649.1% | 321,684 | +2959.3% | 0.00% | – |
| Q1 2022 | $110,000 | -97.6% | 10,515 | -94.9% | 0.00% | -100.0% |
| Q3 2021 | $4,673,000 | -22.3% | 207,030 | -11.4% | 0.00% | -25.0% |
| Q2 2021 | $6,017,000 | -64.2% | 233,661 | -42.1% | 0.00% | -66.7% |
| Q1 2021 | $16,828,000 | – | 403,836 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $69,216,825 | 18.48% |
| CHI Advisors LLC | 3,414,189 | $30,898,410 | 12.25% |
| Nextech Invest Ltd. | 1,221,145 | $11,051,362 | 3.35% |
| TANG CAPITAL MANAGEMENT LLC | 621,138 | $5,621,299 | 0.79% |
| BVF INC/IL | 3,196,701 | $28,930,144 | 0.78% |
| Parkman Healthcare Partners LLC | 438,745 | $3,970,642 | 0.73% |
| Velan Capital Investment Management LP | 75,000 | $678,750 | 0.55% |
| BRAIDWELL LP | 1,908,865 | $17,275,228 | 0.55% |
| Boxer Capital, LLC | 1,074,082 | $9,720,442 | 0.52% |
| DAFNA Capital Management LLC | 127,284 | $1,151,920 | 0.36% |